- Home
- RDNT
RDNT
RadNet Inc.
as 12-20-2024 3:41pm EST
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments; The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures, and Artificial Intelligence segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company derives a majority of its revenue from the Imaging center segment.
| Founded: | 1985 | Country: | United States |
| Employees: | N/A | City: | LOS ANGELES |
| Market Cap: | 6.0B | IPO Year: | 1986 |
| Target Price: | $84.75 | AVG Volume (30 days): | 515.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.07 | EPS Growth: | N/A |
| 52 Week Low/High: | $33.44 - $93.65 | Next Earning Date: | 11-10-2024 |
| Revenue: | $1,772,946,000 | Revenue Growth: | 12.20% |
| Revenue Growth (this year): | 14.93% | Revenue Growth (next year): | 8.83% |
Stock Insider Trading Activity of RadNet Inc. (RDNT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Katz David Jeffrey | RDNT | EVP and Chief Legal Officer | Nov 25 '24 | Sell | $81.72 | 12,300 | $1,004,252.10 | 68,019 | |
| Jayanathan Ranjan | RDNT | Chief Information Officer | Nov 19 '24 | Sell | $80.00 | 38,557 | $3,084,560.00 | 192,724 |
Latest RadNet Inc. News
RDNT Breaking Stock News: Dive into RDNT Ticker-Specific Updates for Smart Investing
Investor's Business Daily
2 days ago
DaVita Stock Sees Improved Relative Strength Rating
Simply Wall St.
3 days ago
When Should You Buy RadNet, Inc. (NASDAQ:RDNT)?
Argus Research
4 days ago
RDNT: Lowering target price to $80.00
Argus Research
11 days ago
RDNT: Lowering target price to $83.00
PR Newswire
18 days ago
Ketryx Announces DeepHealth Selected Its Software to Accelerate AI-Powered Health Informatics Innovation
Argus Research
18 days ago
RDNT: Lowering target price to $85.00
Zacks
19 days ago
RDNT Stock Up Post New Tie-Up to Boost Ultrasound Workflows With AI
Zacks
20 days ago
RDNT Stock Up Following the New Tie-Up to Leverage Radiology AI
Compare RDNT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RDNT RadNet Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.